Skip to content
10-K

Annual Report

REMEDENT, INC.

0001144204-18-038347

← back to feed
Filed
Jul 13, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Jul 13, 2018 20M sh
Shares Diluted FY 2018 · Mar 31, 2017 20M sh
Operating Cash Flow FY 2018 · Mar 31, 2017 $1.67M
Stockholders Equity FY 2018 · Mar 31, 2017 $3.11M
Current Liabilities FY 2018 · Mar 31, 2017 $1.55M
Current Assets FY 2018 · Mar 31, 2017 $1.28M
Total Assets FY 2018 · Mar 31, 2017 $4.73M
Eps Diluted FY 2018 · Mar 31, 2017 $0.04
Eps Basic FY 2018 · Mar 31, 2017 $0.04
Sga Expense FY 2018 · Mar 31, 2017 $1.45M
Rd Expense FY 2018 · Mar 31, 2017 $8.42K
Net Income FY 2018 · Mar 31, 2017 $844.37K
Operating Income FY 2018 · Mar 31, 2017 −$1.07M
Gross Profit FY 2018 · Mar 31, 2017 $1.19M
Cash And Equivalents FY 2018 · Mar 31, 2016 $94.43K